BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

539206

GVBL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GENOMIC VALLEY BIOTECH LIMITED Share Price Update

As of the latest trading session, GENOMIC VALLEY BIOTECH LIMITED share price is currently at ₹ 61.5, which is down by ₹ -0.50 from its previous closing. Today, the stock has fluctuated between ₹ 61.50 and ₹ 61.50. Over the past year, GENOMIC VALLEY BIOTECH LIMITED has achieved a return of 102.36 %. In the last month alone, the return has been 10.47 %. Read More...

GENOMIC VALLEY BIOTECH LIMITED fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    18.80

  • P/E Ratio (TTM)

    48.81

  • Beta

    0.59

  • Book Value / share

    12.49

  • Return on equity

    0.57%

  • EPS (TTM)

    1.26

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.16

info icon alternate text

GENOMIC VALLEY BIOTECH LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.22
Operating Expense 0.07
Net Profit 0.16
Net Profit Margin (%) 72.72
Earnings Per Share (EPS) 0.51
EBITDA 0.16
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.21
Operating Expense 0.06
Net Profit 0.15
Net Profit Margin (%) 71.42
Earnings Per Share (EPS) 0.48
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.16
Operating Expense 0.03
Net Profit 0.13
Net Profit Margin (%) 81.25
Earnings Per Share (EPS) 0.42
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.15
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.04
Operating Expense 0.02
Net Profit 0.02
Net Profit Margin (%) 50.00
Earnings Per Share (EPS) 0.07
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.17
Operating Expense 0.15
Net Profit 0.02
Net Profit Margin (%) 11.76
Earnings Per Share (EPS) 0.05
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 2.72
Operating Expense 1.85
Net Profit 0.65
Net Profit Margin (%) 23.89
Earnings Per Share (EPS) 2.12
EBITDA 0.66
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.07
Operating Expense 0.57
Net Profit -0.01
Net Profit Margin (%) -14.28
Earnings Per Share (EPS) -0.03
EBITDA 0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.21
Operating Expense 0.72
Net Profit -0.56
Net Profit Margin (%) -266.66
Earnings Per Share (EPS) -1.83
EBITDA -0.13
Effective Tax Rate (%) -12.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.85
Operating Expense 0.65
Net Profit 0.29
Net Profit Margin (%) 34.11
Earnings Per Share (EPS) 0.94
EBITDA 0.57
Effective Tax Rate (%) -38.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.60
ROE % 0.57
ROCE % 0.57
Total Debt to Total Equity 0.00
EBITDA Margin 11.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.55
ROE % 28.48
ROCE % 25.67
Total Debt to Total Equity 0.00
EBITDA Margin 33.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.21
EBITDA Margin -428.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.69
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.32
EBITDA Margin -61.90
Particulars MAR 2020 (Values in Cr)
Book Value / Share 16.52
ROE % 5.84
ROCE % 5.39
Total Debt to Total Equity 0.30
EBITDA Margin 65.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 4.33
Total Liabilities 4.33
Total Equity 3.54
Share Outstanding 3054500
Price to Book Ratio 2.99
Return on Assets (%) 0.35
Return on Capital (%) 0.43
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.42
Total Liabilities 4.42
Total Equity 3.52
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) 14.66
Return on Capital (%) 18.38
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 3.79
Total Liabilities 3.79
Total Equity 2.87
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) -0.24
Return on Capital (%) -0.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.61
Total Liabilities 7.61
Total Equity 4.48
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) -7.33
Return on Capital (%) -9.26
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 8.00
Total Liabilities 8.00
Total Equity 5.04
Share Outstanding 3054500
Price to Book Ratio 0.00
Return on Assets (%) 3.57
Return on Capital (%) 4.38
Particulars MAR 2024 (Values in Cr)
Net Income 0.01
Cash from Operations -0.02
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow -0.02
Particulars MAR 2023 (Values in Cr)
Net Income 0.91
Cash from Operations -0.77
Cash from Investing 1.52
Cash from Financing -0.70
Net change in Cash 0.03
Free Cash Flow -0.77
Particulars MAR 2022 (Values in Cr)
Net Income -0.42
Cash from Operations -2.12
Cash from Investing 3.66
Cash from Financing -1.54
Net change in Cash 0.00
Free Cash Flow -2.12
Particulars MAR 2021 (Values in Cr)
Net Income -0.50
Cash from Operations 1.48
Cash from Investing -1.57
Cash from Financing 0.06
Net change in Cash -0.02
Free Cash Flow 3.06
Particulars MAR 2020 (Values in Cr)
Net Income 0.20
Cash from Operations 0.43
Cash from Investing -0.47
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow 0.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
KESORAM INDUSTRIES LTD 4.01 0.00 0.27 124.59 2.94 / 11.79
MODI RUBBER LTD 130.80 14.58 0.59 327.52 86.05 / 163.90
THOMAS COOK (INDIA) LTD 134.55 25.48 4.12 6335.87 118.10 / 264.00
RAIN INDUSTRIES LIMITED 141.85 0.00 0.71 4771.12 117.30 / 196.95
GANESH BENZOPLAST LIMITED 119.80 13.15 1.61 862.43 100.70 / 179.90
Company Name Price P/E P/B Market Cap 52 Week Low/High
FGP LTD. 9.50 50.00 3.03 11.30 6.37 / 14.18
KESORAM INDUSTRIES LTD 4.01 0.00 0.22 124.59 2.94 / 11.79
MPIL CORPORATION LTD. 640.00 0.00 2.43 36.48 506.00 / 950.00
MODI RUBBER LTD 130.80 30.35 1.21 327.52 86.05 / 163.90

GENOMIC VALLEY BIOTECH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
61.50 -0.80 redarrow
red-green-graph indicator
10 Bearish
6 Bullish
  • 5 Days 62.10
  • 26 Days 60.50
  • 10 Days 61.70
  • 50 Days 61.10
  • 12 Days 61.50
  • 100 Days 64.60
  • 20 Days 60.80
  • 200 Days 64.10
61.67 PIVOT

First Support

61.33

First Resistance

62.33

Second Support

60.67

Second Resistance

62.67

Third Support

60.33

Third Resistance

63.33

RSI

53.33

ADX

12.84

MACD

0.97

Williams % R

-17.84

Commodity Channel Index (CCI)

40.60

Date

2025-04-30

Week

152.00

Same Day

30.00

Month

855.00

1 Year

0.60

3 Year

0.37

Over 1 Month

10.47%

down

Over 1 Year

102.36%

down

Over 3 Months

26.80%

down

Over 3 Years

29.14%

down

Over 6 Months

-37.86%

down

Over 5 Years

46.57%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

GENOMIC VALLEY BIOTECH LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
53.21%
Promoter Holdings
46.78%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Yogesh Agrawal 1427000.0 (46.72%) Shareholding of Promoter and Promoter Group
Deepti Aggarwal 336000.0 (11.0%) Public Shareholding
Amar Aggarwal 276510.0 (9.05%) Public Shareholding
Vikram Ashokkumar Jain 168100.0 (5.5%) Public Shareholding
Purushothaman Shaji 82170.0 (2.69%) Public Shareholding
Ojaswini Avantika 2000.0 (0.07%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

GENOMIC VALLEY BIOTECH LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

GENOMIC VALLEY BIOTECH LIMITED Share Price

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally. The Company is extensively involved in commercial greenhouse / poly house cultivation of crops. Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer. Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

The Company identified a cluster of 300 marginal farmers eligible to form a Farmers Producer Company. It already started opening a training centre, imparting training to farmers and agri-entrepreneurs profitably. Separate courses have been designed for Training like the Ladies to develop kitchen gardens or small farms which can fetch them profits by growing fruits and vegetables. Apart from this, the Company is also providing Agri Farming Consultancy to farmers and other clients on case to case basis.

The Company is taking up turnkey cultivation projects of its clients on clients land with assured buy back and marketing assurance. And finally when production of vegetables comes, the Company shoulders all responsibilities to sell produce in the market to pay the assured amount to client. The Company is having a commercial plant tissue culture laboratory and has the production capacity of 3 million plants per annum.

The Company is in process to do all the documentations for getting started with the operation of the Producer Company.

Parent organization Indian Private
NSE symbol [-]
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Genomic Valley Biotech Ltd?

Answer Field

The share price of Genomic Valley Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 61.50.

What is the Market Cap of Genomic Valley Biotech Ltd?

Answer Field

The market cap of Genomic Valley Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 18.80 Cr. as of now.

What is the 52 Week High and Low of Genomic Valley Biotech Ltd?

Answer Field

The 52 Week High and Low of Genomic Valley Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 108.15 and ₹ 28.36.

How to Buy Genomic Valley Biotech Ltd share?

Answer Field

You can trade in Genomic Valley Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Genomic Valley Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 102.36%.

What is the Current Share Price of Genomic Valley Biotech Ltd?

Answer Field

Genomic Valley Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 61.50 as on Apr 30 2025 01:15 PM.

What is the Market Cap of Genomic Valley Biotech Ltd Share?

Answer Field

The market cap of Genomic Valley Biotech Ltd for NSE ₹ 0.0 & for BSE ₹ 18.80 as on Apr 30 2025 01:15 PM.

What is the P/E Ratio of Genomic Valley Biotech Ltd Share?

Answer Field

As on Apr 30 2025 01:15 PM the price-to-earnings (PE) ratio for Genomic Valley Biotech Ltd share is 48.81.

What is the PB ratio of Genomic Valley Biotech Ltd Share?

Answer Field

As on Apr 30 2025 01:15 PM, the price-to-book (PB) ratio for Genomic Valley Biotech Ltd share is 12.49.

How to Buy Genomic Valley Biotech Ltd Share?

Answer Field

You can trade in Genomic Valley Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Genomic Valley Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Genomic Valley Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Genomic Valley Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|